# Harmony Biosciences: Biopharma, Plymouth Meeting, United States

> Harmony Biosciences: Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Source: https://millionrounds.com/startup/harmony-biosciences (Millionrounds; every figure on the page links to its filing or article)

United States · [Biopharma startup](https://millionrounds.com/companies)

# Harmony Biosciences

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Funding reported Last round: Post ipo debt

Biopharma Plymouth Meeting, United States

Company summary

- **Founded:** 2017 9 years old
- **Team:** 251 201 to 1,000 people
- **Funding reported:** $1.4B in dollars
- **Last round:** Post ipo debt Jul 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Harmony Biosciences has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Harmony Biosciences raised

Funding, as reported

Reported in all **$1.4B** in dollars

Rounds **8**

Last round **Post ipo debt**

Last round date **Jul 2023**

Investors listed **11**

## Founders and team

From Harmony Biosciences's own website: 1 founder, 9 on the team.

**Jeffrey S. Aronin** Harmony Founder and Non-Executive Chairman

- **Cate McCanless** Senior Vice President and Chief Corporate Affairs Officer
- **Harmony Biosciences** President and Chief Executive Officer
- **Orbital Therapeutics** Chief Executive Officer
- **Ron Philip** President and Chief Executive Officer
- **Audrey Murphy** Chief Human Resources Officer
- **Peter Anastasiou** Chief Operating Officer
- **Tricia Glover** Chief Compliance Officer
- **Troy Ignelzi** Chief Financial Officer
- **Juan Sabater** Partner

## On 2 portfolio pages

Investors who name them

- [Valor Equity Partners](https://millionrounds.com/fund/valor-equity-partners)
- [Aisling Capital](https://millionrounds.com/fund/aisling-capital)

Each firm lists Harmony Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biopharma in United States

Startups like it

- [**Altos Labs** San Francisco · founded 2021](https://millionrounds.com/startup/altos-labs)
- [**Vaxcyte** San Carlos · founded 2013](https://millionrounds.com/startup/vaxcyte)
- [**Madrigal Pharmaceuticals** Conshohocken · founded 2011](https://millionrounds.com/startup/madrigal-pharmaceuticals)
- [**Kura Oncology** La Jolla · founded 2014](https://millionrounds.com/startup/kura-oncology)
- [**Immunovant** New York · founded 2018](https://millionrounds.com/startup/immunovant)
- [**Solugen** Houston · founded 2016](https://millionrounds.com/startup/solugen-2)
- [**Dianthus Therapeutics** Waltham · founded 2019](https://millionrounds.com/startup/dianthus-therapeutics)
- [**Day One Biopharmaceuticals** South San Francisco · founded 2018](https://millionrounds.com/startup/day-one-biopharmaceuticals)

## Is this your company?

Add your raise, your deck and your story, and put Harmony Biosciences in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)